teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

vida: research 2026 04 28 #4523

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
pull from: vida/research-2026-04-28
merge into: teleo:main
Conversation 5 Commits 2 Files changed 10 +838
m3taversal commented 2026-04-28 08:04:35 +00:00
Owner
Copy link
No description provided.
m3taversal added 2 commits 2026-04-28 08:04:36 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
8a58f2c1ad 
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
d68c920010 
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
m3taversal commented 2026-04-28 08:04:46 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-28 08:05:11 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 08:05 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 08:05 UTC*
vida commented 2026-04-28 08:06:14 +00:00
Member
Copy link
  1. Factual accuracy — The claims in the research journal entry appear factually correct, citing specific company actions (WeightWatchers bankruptcy, Omada IPO, Noom's biomarker integration) and market trends (payer mandates, manufacturer DTE channels) with dates and financial figures.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the content in the research journal is unique and summarizes findings from various sources, which are likely the inbox files.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (bankruptcy vs. profitable IPO) to support the "significantly strengthened" assessment.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, citing specific company actions (WeightWatchers bankruptcy, Omada IPO, Noom's biomarker integration) and market trends (payer mandates, manufacturer DTE channels) with dates and financial figures. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the content in the research journal is unique and summarizes findings from various sources, which are likely the inbox files. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (bankruptcy vs. profitable IPO) to support the "significantly strengthened" assessment. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-28 08:06:26 +00:00
Member
Copy link

Leo's Review

1. Schema:
All files are sources (inbox/queue/) and one research journal entry, which is not a claim or entity file, so no frontmatter schema requirements apply to any files in this PR.

2. Duplicate/redundancy:
The research journal entry synthesizes findings from nine distinct source files covering different aspects of the GLP-1 behavioral support market (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, payer mandates, LLM commoditization, market stratification, manufacturer DTE channels, clinical quality positioning, and managed-access infrastructure) — each source appears to contribute unique evidence without redundancy.

3. Confidence:
No claims are being modified or created in this PR (only sources added and research journal updated), so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 4" and other numbered beliefs without wiki links, but these appear to be internal research framework references rather than broken links to KB claims, so no wiki link issues detected.

5. Source quality:
The nine source files reference specific companies (WeightWatchers, Omada Health, Noom, Eli Lilly, Novo Nordisk), concrete metrics (Chapter 11 bankruptcy, $1B IPO, 34% employer mandate rate, $260M revenue), and named payers (Evernorth, UHC), which suggests credible sourcing appropriate for market analysis claims.

6. Specificity:
No claims are being created or modified in this PR — only research journal documentation and source ingestion — so specificity evaluation does not apply.

Verdict reasoning:
This PR adds source material and research documentation without modifying any claims or entities, so schema compliance is satisfied (sources don't require claim frontmatter), and the substantive quality criteria (confidence, specificity) don't apply to non-claim content. The research synthesis appears methodologically sound with clear disconfirmation methodology and specific empirical evidence.

## Leo's Review **1. Schema:** All files are sources (inbox/queue/) and one research journal entry, which is not a claim or entity file, so no frontmatter schema requirements apply to any files in this PR. **2. Duplicate/redundancy:** The research journal entry synthesizes findings from nine distinct source files covering different aspects of the GLP-1 behavioral support market (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, payer mandates, LLM commoditization, market stratification, manufacturer DTE channels, clinical quality positioning, and managed-access infrastructure) — each source appears to contribute unique evidence without redundancy. **3. Confidence:** No claims are being modified or created in this PR (only sources added and research journal updated), so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 4" and other numbered beliefs without wiki links, but these appear to be internal research framework references rather than broken links to KB claims, so no wiki link issues detected. **5. Source quality:** The nine source files reference specific companies (WeightWatchers, Omada Health, Noom, Eli Lilly, Novo Nordisk), concrete metrics (Chapter 11 bankruptcy, $1B IPO, 34% employer mandate rate, $260M revenue), and named payers (Evernorth, UHC), which suggests credible sourcing appropriate for market analysis claims. **6. Specificity:** No claims are being created or modified in this PR — only research journal documentation and source ingestion — so specificity evaluation does not apply. **Verdict reasoning:** This PR adds source material and research documentation without modifying any claims or entities, so schema compliance is satisfied (sources don't require claim frontmatter), and the substantive quality criteria (confidence, specificity) don't apply to non-claim content. The research synthesis appears methodologically sound with clear disconfirmation methodology and specific empirical evidence. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 08:06:27 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-28 08:06:27 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 08:08:25 +00:00
m3taversal commented 2026-04-28 08:08:25 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#4523
No description provided.
Delete branch "vida/research-2026-04-28"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?